SWISS NATIONAL BANK – Vertex Pharmaceuticals Incorporated Transaction History
SWISS NATIONAL BANK portfolio value:
$320.91M
portfolio value
SWISS NATIONAL BANK quarter portfolio value change:
+2.75%
quarter
Vertex Pharmaceuticals Incorporated 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Increase | +0.37% | 4.1K shares | 9.74M | $289.54 | 1.10M |
Q2 2022 | share | Increase | +0.28% | 3.1K shares | 23.8M | $281.79 | 1.10M |
Q1 2022 | share | Increase | +11.67% | 115.1K shares | 70.83M | $260.97 | 1.10M |
Q4 2021 | share | Decrease | -3.67% | -37.6K shares | 30.85M | $222.45 | 986.07K |
Q3 2021 | share | Decrease | -3.42% | -36.3K shares | -28.03M | $181.39 | 1.02M |
Q2 2021 | share | Decrease | -28.81% | -429K shares | -106.24M | $201.63 | 1.05M |
Q1 2021 | share | Increase | +1.47% | 21.5K shares | -26.85M | $214.89 | 1.48M |
Q4 2020 | share | Increase | +5.56% | 77.3K shares | -31.47M | $236.34 | 1.46M |
Q3 2020 | share | Increase | +17.24% | 204.4K shares | 34.05M | $272.12 | 1.39M |
Q2 2020 | share | Increase | +14.45% | 149.7K shares | 97.70M | $290.31 | 1.18M |
Q1 2020 | share | Increase | +24.80% | 205.9K shares | 64.76M | $237.95 | 1.03M |
Q4 2019 | share | Decrease | -4.02% | -34.8K shares | 35.22M | $218.95 | 830.17K |
Q3 2019 | share | Increase | +1.27% | 10.86K shares | -10.08M | $169.42 | 864.97K |
Q2 2019 | share | Increase | +0.14% | 1.2K shares | -266K | $183.38 | 854.10K |
Q1 2019 | share | Increase | +2.65% | 22K shares | 19.20M | $183.95 | 852.90K |
Q4 2018 | share | Increase | +2.14% | 17.4K shares | -19.10M | $165.71 | 830.90K |
Q3 2018 | share | Decrease | -3.02% | -25.3K shares | 14.23M | $192.74 | 813.50K |
Q2 2018 | share | Increase | +3.38% | 27.4K shares | 10.32M | $169.96 | 838.80K |
Q1 2018 | share | Decrease | -12.66% | -117.6K shares | -6.97M | $162.98 | 811.40K |
Q4 2017 | share | Increase | +1.18% | 10.8K shares | -383K | $149.86 | 929.00K |
Q3 2017 | share | Increase | +1.22% | 11.1K shares | 22.70M | $152.04 | 918.20K |
Q2 2017 | share | Increase | +3.22% | 28.3K shares | 20.80M | $128.87 | 907.10K |
Q1 2017 | share | Increase | +27.40% | 189K shares | 45.28M | $109.35 | 878.80K |
Q4 2016 | share | Increase | +0.70% | 4.8K shares | -8.92M | $73.67 | 689.80K |
Q3 2016 | share | Decrease | -0.81% | -5.6K shares | 334K | $87.21 | 685.00K |
Q2 2016 | share | Increase | +8.18% | 52.2K shares | 10.77M | $86.02 | 690.60K |
Q1 2016 | share | Increase | +43.62% | 193.9K shares | -7.29M | $79.49 | 638.40K |